For a couple of days at least, there's been a craving for the 'old normal'. But the past is never quite what it seemed. The mere glimpse of economic and political 'normality' returning with this week's U.S. election results and COVID-19 vaccine breakthrough prompted a scramble for burnt-out 'value' stocks, bonds and currencies and away from lockdown winners, safe-havens and anti-globalisation plays.
Pandemic payment breaks on European loans totalling billions of euros threaten to undermine efforts by the region's banks to put the coronavirus crisis behind them.
Bahrain's veteran prime minister Sheikh Khalifa bin Salman Al Khalifa quashed repeated opposition unrest in almost half a century in office and was a fierce critic of the Arab Spring, saying it had brought Arabs only "death, chaos and destruction".
Japan's traditionally overlooked stock market is winning new fans as global investors use the promise of a coronavirus vaccine and a new U.S. administration to hunt for more fairly valued, growth-oriented markets.
Malaysia's economy likely contracted at a slower pace in the third quarter after easing coronavirus restrictions helped revive consumption and output, a Reuters poll showed on Wednesday.
Russian President Vladimir Putin has brokered a Nagorno-Karabakh peace deal that locks in territorial gains for Turkey-backed Azerbaijan. In doing so, he has thwarted a stronger Turkish presence in a region Moscow views as its backyard.
Turkey's current account is expected to record a deficit of $2.7 billion in September, a Reuters poll showed on Monday, as the estimate for the full-year deficit continued to increase from previous months.
Crexendo (CXDO) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.
The third quarter earnings results continue to come in stronger than projected and the outlook for the fourth quarter and beyond is steadily improving. And stocks posted their best week since April last week, before they climbed to new records Monday on the back of Pfizer’s Cov
Capstone Turbine (CPST) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items.
Ashland (ASH) came out with quarterly earnings of $0.99 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.77 per share a year ago. These figures are adjusted for non-recurring items.
Coherent (COHR) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.89 per share a year ago. These figures are adjusted for non-recurring items.
Perspecta (PRSP) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.54 per share a year ago. These figures are adjusted for non-recurring items.
Azure Power (AZRE) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.
Vectrus (VEC) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.80 per share a year ago. These figures are adjusted for non-recurring items.
Almost two-thirds of people in Britain say they would get vaccinated for COVID-19 but young people are far more likely to refuse a jab than older people, according to an opinion poll published on Wednesday.
Brooks Automation (BRKS) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.30 per share a year ago. These figures are adjusted for non-recurring items.
Kornit Digital (KRNT) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.
Alector (ALEC) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items.